Purdue Pharma, the manufacturer of the narcotic pain reliever, is expected to report revenue under $1 billion for the first time in over a decade and is reportedly considering bankruptcy. The company, controlled by the wealthy Sackler family, is besieged by legal challenges over its role in the opioid crisis and mounting probes into fraud allegations. Meanwhile, employees are heading for the door in droves amid widespread corporate restructuring.
Is Purdue to blame for the crisis? While OxyContin has fallen out of favor with doctors in recent years, the firm is accused of aggressively marketing the medication despite deadly consequences.
OZY takes a look at Trump’s pharma policies.